Veterinary Medicines

Bovilis BVD suspensija injekcijām liellopiem

Authorised
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
Download as PDF

Product identification

Medicine name:
Bovilis BVD suspensija injekcijām liellopiem
Active substance:
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
Target species:
  • Cattle (cow)
  • Cattle (heifer)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine viral diarrhoea virus 1, strain C-86, Inactivated
    satur 50 ELISA vienības (EU) un inducē ne mazāk kā 4,6 log2 VN vienības
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (cow)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • PVD
Authorisation number:
  • V/NRP/02/1524
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 31/01/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."